Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

China · Delayed Price · Currency is CNY

25.94

+0.93 (3.72%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Pharmaceuticals	470.79M	497.29M	507.38M	438.99M	375.43M
Pharmaceuticals Growth	-5.33%	-1.99%	15.58%	16.93%	5.71%
Total	470.79M	497.29M	507.38M	438.99M	375.43M
Total Growth	-5.33%	-1.99%	15.58%	16.93%	5.71%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013	FY 2012
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
South China	118.48M	-	-	-	-
East China	144.59M	-	-	-	-
North China	65.84M	-	-	-	-
Northwest China	34.62M	-	-	-	-
Central China	45.50M	-	-	-	-
Southwest China	49.09M	-	-	-	-
Northeast China	6.29M	-	-	-	-
Overseas	390.58K	-	-	-	-
Total	464.80M	-	-	-	-

Source: S&P Global Market Intelligence.